PD-L1-R: A MR based surrogate for PD-L1 expression in Glioblastoma multiforme.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.2041
Abstract: 2041Background: Efficacy of PD-L1 immune checkpoint inhibitor therapy in Glioblastoma multiforme (GBM) is limited and the prognostic value of PD-L1 in GBM is an active field of research. We therefo... read more here.
Keywords: glioblastoma; surrogate expression; expression glioblastoma; based surrogate ... See more keywords